Vimarsana
Biggest News Aggregation in the World

Rebound Back News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rebound Back. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rebound Back Today - Breaking & Trending Today

recruitment: Altimetrik looks to grow ratio of women employees in India by 10% over the year - Vimarsana News

recruitment: Altimetrik looks to grow ratio of women employees in India by 10% over the year

Synopsis Altimetrik aims to grow its India ratio of women employees from 22% to 32% incrementally by the end of 2021 through its digital talent platform, sensitisation, skilling and mental wellness initiatives. Getty Images US-based Altimetrik has rolled out a new initiative under its diversity mandate in india. The ‘Women’s Initiative for Networking Growth and Success’ (WINGS) programme will focus on hiring women in India. The programme has been launched for women employees in India first before the global rollout. The company also aims to grow its India ratio of women employees from 2...

Detailed text transcripts for TV channel - FOXNEWS - 20190622:14:46:00 - Vimarsana News

Detailed text transcripts for TV channel - FOXNEWS - 20190622:14:46:00

Continue, this will have a significant impact on the way the consumer spends. i mean if, when you talk about oil prices going up the way they are, that's going to have an impact on not only gasoline prices, but that's going to have an impact on what we purchase at the stores -- neil: but it hasn't yet. and charles, one of your points has been that this, there are other factors at play that are countering this, right? >> yeah. ten months of strong wage growth, typically for blue collar workers. something we haven't seen in well over a decade. you know, even the last consumer confidence report f...

Detailed text transcripts for TV channel - MSNBC - 20140307:16:30:00 - Vimarsana News

Detailed text transcripts for TV channel - MSNBC - 20140307:16:30:00

Here? as it relates to these babies and circumstances, i should say. >> well, these kinds of clinical trials, if you want to get the data that really is definitive, convincing data with regard to both the safety and the long-term ethicacy, these trials take a number of years because you're going to have to treat the baby for a considerable period of time before you empirically decide in a controlled way to stop therapy and follow the baby very, very carefully to make sure the virus doesn't rebound back, and if it does, to reinstitute the therapy in the baby, because the first thing you want to...